Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Triclosan ÇÔÀ¯Ä¡¾àÀÌ Ä¡ÅÂ, Ä¡Àº¿° ¹× Ä¡¼®Çü¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ¿¬±¸

Clinical efficacy of triclosan containing dentifrice in control of plaque, gingivitis, and calculus

´ëÇѱ¸°­º¸°ÇÇÐȸÁö 1998³â 22±Ç 1È£ p.27 ~ 36
¾çÈ«¼­, ÃÖÀ¯Áø, Á¤¼º¼÷, °­ÃæÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÈ«¼­ ( Yang Hong-So ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¿¹¹æÄ¡°úÇб³½Ç
ÃÖÀ¯Áø (  ) - °æÈñ´ëÇб³ Ä¡°ú´ëÇÐ ¿¹¹æÄ¡°úÇб³½Ç
Á¤¼º¼÷ (  ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¿¹¹æÄ¡°úÇб³½Ç
°­ÃæÈñ (  ) - Àü³²´ëÇб³ Ä¡°ú´ëÇÐ ¿¹¹æÄ¡°úÇб³½Ç

Abstract

°á·Ð
Triclosan ÇÔÀ¯Ä¡¾àÀº ±¸°­ À§»ý°ú Ä¡Àº °Ç°­, Ä¡¼®Çü¼ºÀÇ ¾ïÁ¦¸¦ À§ÇØ ´Ù¾çÇÏ°Ô »ç¿ëµÇ
°í ÀÖ´Ù. º» ¿¬±¸´Â 076% SMFP/calcium carbonate·Î ¹èÇÕµÈ triclosan ÇÔÀ¯Ä¡¾à°ú ºñÇÔÀ¯
Ä¡¾àÀÇ Ä¡ÅÂ, Ä¡Àº¿°, Ä¡¼®Çü¼ºÀÇ ¾ïÁ¦ È¿°ú¸¦ ºñ±³ÇÏ°íÀÚ, 3°³¿ù°£ ÀÌÁß ¸Í°Ë¹ý¿¡ ÀÇÇØ ÀÓ
»ó½ÇÇèÀ» ÇÏ¿´´Ù. 0.5% triclosan°ú 0.1% ALCA¸¦ ÇÔÀ¯ÇÑ triclosanÇÔÀ¯Ä¡¾àÀº triclosan°ú
ALCA¸¦ Á¦¿ÜÇÏ°í ºñÇÔÀ¯Ä¡¾à°ú µ¿ÀÏÇÑ ±¸¼ººñ·Î ¹èÇյǾú´Ù. Ä¡Å ¹× Ä¡ÀºÁö¼öÀÇ ´ë»óÀÚ
´Â 30´ë ¼ºÀÎ 73¸íÀ̾úÀ¸¸ç, Ä¡¼®Áö¼öÀÇ ´ë»óÀÚ´Â 53¸íÀ̾ú´Ù. Ä¡¼®Á¦°Å¸¦ Æ÷ÇÔÇÑ Ã¶ÀúÇÑ Ä¡
¸é¼¼¸¶¸¦ ½Ç½ÃÇÏ¿´°í, 2ÁÖÀÏ µ¿¾È triclosan ºñÇÔÀ¯Ä¡¾àÀÇ »ç¿ë ÈÄ ±âÃÊ Ä¡Å ¹× Ä¡ÀºÁö¼ö¸¦
ÃøÁ¤ÇÏ¿´´Ù. 3°³¿ù°£ triclosan ÇÔÀ¯Ä¡¾à°ú ºñÇÔÀ¯Ä¡¾àÀ¸·Î ÇÏ·ç 3ȸ À̸¦ ´Û°Ô ÇÏ¿´À¸¸ç, ½Ç
Çè±â°£ µ¿¾È º¸Á¶±¸°­À§»ý¿ëÇ°ÀÇ »ç¿ë ¹× Ä¡°úÄ¡·á¸¦ ±ÝÇÏ¿´´Ù. 3°³¿ù µ¿¾È Ä¡¾à »ç¿ë ÈÄ
Silness¿Í LoeÀÇ Ä¡ÅÂ, Ä¡ÀºÁö¼ö ¹× Volpe¿Í ManholdÀÇ Ä¡¼®Áö¼ö¸¦ ÃøÁ¤ÇÏ¿´´Ù. 3°³¿ù°£
triclosanÇÔÀ¯Ä¡¾à°ú ºñÇÔÀ¯Ä¡¾àÀÇ »ç¿ë¿¡ ÀÇÇÑ Ä¡ÅÂ, Ä¡Àº¿°, Ä¡¼® Çü¼º È¿°ú¸¦ ºñ±³ÇÏ¿© ´Ù
À½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù.
1. TriclosanÇÔÀ¯Ä¡¾à »ç¿ë¿¡ ÀÇÇØ Ä¡ÅÂÁö¼ö´Â 0.10¡¾0.21ÀÇ À¯ÀÇÇÑ °¨¼Ò¸¦ º¸¿´À¸³ª
(p<0.05), ºñÇÔÀ¯Ä¡¾à »ç¿ë±ºÀº À¯ÀÇÇÑ °¨¼Ò¸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù (p>0.05).
2. TriclosanÇÔÀ¯Ä¡¾à»ç¿ë¿¡ ÀÇÇØ Ä¡ÀºÁö¼ö´Â 0.15¡¾0.20ÀÇ À¯ÀÇÇÑ °¨¼Ò¸¦ º¸¿´À¸³ª, ºñÇÔ
À¯Ä¡¾à »ç¿ë±ºÀº À¯ÀÇÇÑ °¨¼Ò¸¦ º¸ÀÌÁö ¾Ê¾ÒÀ¸¸ç, triclosanÇÔÀ¯Ä¡¾à »ç¿ë¿¡ ÀÇÇØ triclosanºñ
ÇÔÀ¯Ä¡ ¾à »ç¿ë±ºº¸´Ù À¯ÀÇÇÑ Ä¡Àº Áö¼öÀÇ °¨¼Ò¸¦ º¸¿´´Ù(p>0.05).
3. TriclosanÇÔÀ¯Ä¡¾à »ç¿ë±ºÀÇ Ä¡¼®Áö¼ö´Â 2.87 ¡¾ 2.23À¸·Î ºñÇÔÀ¯Ä¡¾à»ç¿ë±ºÀÇ 3.17¡¾
2.20º¸´Ù ³·¾ÒÀ¸³ª À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù(p>0.05).
ÀÌ»óÀÇ °á°ú·Î º¸¾Æ triclosanÇÔÀ¯Ä¡¾àÀº Ä¡Å Çü¼º ¹× Ä¡Àº¿°ÀÇ ¹ß»ý ¾ïÁ¦¿¡ È¿°úÀûÀ̶ó
°í »ç·áµÇ¾ú´Ù.

A double blind, three month clinical study was conducted to determine the effect of
triclosan containing test dentifrice on supragingival plaque, gingivitis and supragingival
calculus formation compared to a 0.76 precent monofluorophosphate-calcium carbonate
dentifrice. Test dentifrice had the same formulation as the control except it contained 0.3
percent triclosan and 0.1 percent aluminium chlorohydroxy allantoinate. Seventy-three
adults aged from 31 to 39 years, were included in this study. Subjects were randomly
assigned to test group or to control group according to baseline plaque (Silness-L e),
gingivitis (Silness-L e), and calculus (modified Volpe-Manhold) scores. Subjects brushed
three times daily in their customary manner, and refrained from using any other hygiene
products and any dental treatment. Subjects were evaluated for plaque, calculus
formation, and for gingivitis after 3 months' use of the dentifrices. Test group exhibited
significantly the lower plaque levels and the higher levels of gingival health by the use
of the dentifrice contained triclosan and ALCA throughout 3 months, whereas this
improvement was not showed by control group. However, Levels of calculus was not
improved by the use of the dentifrice contained triclosan and ALCA. The improved
plaque control, stabilized gingival health support the conclusion that a dentifrice
contained 0.3 percent triclosan and 0.1 percent ALCA can contribute to oral health.

Å°¿öµå

Triclosan; Ä¡¾à; Ä¡ÅÂ; Ä¡Àº¿°; Ä¡¼®; triclosan; dentifrice; plaque; gingivitis; calculus;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed